Search results
Results from the WOW.Com Content Network
Siddhartha Mukherjee (Bengali: সিদ্ধার্থ মুখার্জী; born 21 July 1970) [1] is an Indian-American physician, biologist, and author. He is best known for his 2010 book, The Emperor of All Maladies: A Biography of Cancer, that won notable literary prizes including the 2011 Pulitzer Prize for General Nonfiction, [2] and Guardian First Book Award, [3] among others.
This is a list of companies listed on the National Stock Exchange of India (NSE). Contents !–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z !–9 Symbol ...
NSE Indices Limited (formerly known as India Index Services & Products Limited (IISL)), a subsidiary of the National Stock Exchange of India (NSE), ...
NSE has set up NSE Academy Limited to further financial literacy. At present, certifications are available in 46 modules, covering different sectors of financial and capital markets, both at the beginner and advanced levels. The list of various modules can be found at the official site of NSE India.
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories [4] and 2400 collection centers across 7 countries including India. [5] The healthcare company was founded in 1980.
In India, he has launched a Phase 2B study into the use of CAR-T cells—a specialized type of lab-altered T-cells—to battle cancer in a small sample group of patients.
It provides a platform for price discovery and risk management for market participants, contributing to the development of India's commodity markets. National Stock Exchange of India (NSE) in Mumbai, one of the two principal large stock exchanges of India. With the Market cap of 5.23 trillion dollars.
In 2014, Dr Lal PathLabs acquired the APL Clinical Institute of Clinical Laboratory & Research Private Limited. [6] Dr Lal PathLabs launched its IPO in 2015. [7] The company got listed on BSE and NSE on 23 December 2015. [8] In 2021, Dr Lal PathLabs acquired Suburban Diagnostics for an enterprise value of ₹ 925 crore in an all-cash deal. [9]